103 related articles for article (PubMed ID: 24395857)
1. Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada.
Mahmud SM; Kliewer EV; Lambert P; Bozat-Emre S; Demers AA
J Clin Oncol; 2014 Feb; 32(5):438-43. PubMed ID: 24395857
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women.
Shiko Y; Konno R; Konishi H; Sauvaget C; Ohashi Y; Kakizoe T
BMC Infect Dis; 2020 Nov; 20(1):808. PubMed ID: 33153446
[TBL] [Abstract][Full Text] [Related]
3. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.
Kim J; Bell C; Sun M; Kliewer G; Xu L; McInerney M; Svenson LW; Yang H
CMAJ; 2016 Sep; 188(12):E281-E288. PubMed ID: 27378467
[TBL] [Abstract][Full Text] [Related]
4. Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
Krog L; Lycke KD; Kahlert J; Randrup TH; Jensen PT; Rositch AF; Hammer A
Am J Obstet Gynecol; 2024 Apr; 230(4):430.e1-430.e11. PubMed ID: 38569830
[TBL] [Abstract][Full Text] [Related]
5. Introduction of a National HPV vaccination program into Bhutan.
Dorji T; Tshomo U; Phuntsho S; Tamang TD; Tshokey T; Baussano I; Franceschi S; Clifford G
Vaccine; 2015 Jul; 33(31):3726-30. PubMed ID: 26057136
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of HPV vaccination against high grade cervical lesions in Japan.
Konno R; Konishi H; Sauvaget C; Ohashi Y; Kakizoe T
Vaccine; 2018 Dec; 36(52):7913-7915. PubMed ID: 29778520
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Risk Factors of Cervical Dysplasia among Human Immunodeficiency Virus Sero-Positive Females on Highly Active Antiretroviral Therapy in Enugu, Southeastern, Nigeria.
Ogu CO; Achukwu PU; Nkwo PO
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2987-2994. PubMed ID: 31653145
[TBL] [Abstract][Full Text] [Related]
8. The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus.
Dhar JP; Essenmacher L; Dhar R; Magee A; Ager J; Sokol RJ
Hum Vaccin Immunother; 2018; 14(9):2318-2322. PubMed ID: 29708835
[TBL] [Abstract][Full Text] [Related]
9. Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
Palmer TJ; Kavanagh K; Cuschieri K; Cameron R; Graham C; Wilson A; Roy K
J Natl Cancer Inst; 2024 Jun; 116(6):857-865. PubMed ID: 38247547
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.
Deshmukh AA; Cantor SB; Fenwick E; Chiao EY; Nyitray AG; Stier EA; Goldstone SE; Wilkin T; Chhatwal J
Vaccine; 2017 Sep; 35(38):5102-5109. PubMed ID: 28807605
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic human papilloma virus vaccination in patients at risk for cervical dysplasia.
Florence AM; Fogel J; Mozey M; Dave S; O'Dell H; Fatehi M
Minerva Obstet Gynecol; 2024 Apr; 76(2):127-134. PubMed ID: 36193830
[TBL] [Abstract][Full Text] [Related]
12. Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
Mølbak K; Hansen ND; Valentiner-Branth P
PLoS One; 2016; 11(9):e0162520. PubMed ID: 27611088
[TBL] [Abstract][Full Text] [Related]
13. Use of real-world data for HPV vaccine trial follow-up in the Nordic region.
Enerly E; Berger S; Kjær SK; Sundström K; Campbell S; Tryggvadóttir L; Munk C; Hortlund M; ; Joshi A; Saah AJ; Nygård M
Contemp Clin Trials; 2020 May; 92():105996. PubMed ID: 32247041
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia.
Maldonado I; Rodríguez Niño N; Valencia CF; Ortiz D; Ayala N; D'silva L; Castro Villarreal S; Salazar D; Lozano C; Angulo D
Vaccine; 2024 Apr; 42(9):2414-2420. PubMed ID: 38458869
[TBL] [Abstract][Full Text] [Related]
15. Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.
Louvanto K; Eriksson T; Gray P; Apter D; Baussano I; Bly A; Harjula K; Heikkilä K; Hokkanen M; Huhtinen L; Ikonen M; Karttunen H; Nummela M; Söderlund-Strand A; Veivo U; Dillner J; Elfstöm M; Nieminen P; Lehtinen M
Int J Cancer; 2020 Jul; 147(2):440-447. PubMed ID: 31749143
[TBL] [Abstract][Full Text] [Related]
16. Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program.
Pei J; Shu T; Wu C; Li M; Xu M; Jiang M; Zhu C
Front Public Health; 2022; 10():998174. PubMed ID: 36684904
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent HPV vaccine effectiveness against cervical intraepithelial lesion grade 2 or worse in Norway: A registry-based study of 0,9 million Norwegian women.
Orumaa M; Lahlum EJ; Gulla M; Tota J; Nygård M; Nygård S
J Infect Dis; 2024 Apr; ():. PubMed ID: 38658353
[TBL] [Abstract][Full Text] [Related]
18. Vaccination Effectiveness against Human Papillomavirus in Kazakhstan.
Satanova A; Bolatbekova R; Kukubassov Y; Ossikbayeva S; Kaidarova D
Asian Pac J Cancer Prev; 2024 Feb; 25(2):681-688. PubMed ID: 38415556
[TBL] [Abstract][Full Text] [Related]
19. Long-term study of a quadrivalent human papillomavirus vaccine.
Ferris D; Samakoses R; Block SL; Lazcano-Ponce E; Restrepo JA; Reisinger KS; Mehlsen J; Chatterjee A; Iversen OE; Sings HL; Shou Q; Sausser TA; Saah A
Pediatrics; 2014 Sep; 134(3):e657-65. PubMed ID: 25136050
[TBL] [Abstract][Full Text] [Related]
20. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.
Drolet M; Bénard É; Boily MC; Ali H; Baandrup L; Bauer H; Beddows S; Brisson J; Brotherton JM; Cummings T; Donovan B; Fairley CK; Flagg EW; Johnson AM; Kahn JA; Kavanagh K; Kjaer SK; Kliewer EV; Lemieux-Mellouki P; Markowitz L; Mboup A; Mesher D; Niccolai L; Oliphant J; Pollock KG; Soldan K; Sonnenberg P; Tabrizi SN; Tanton C; Brisson M
Lancet Infect Dis; 2015 May; 15(5):565-80. PubMed ID: 25744474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
